Former Chief Financial Officer of $21 Billion Biopharmaceutical Company Indicted for Insider Trading
NEWARK, N.J. – The former chief financial officer for a biopharmaceutical company was indicted today for his role in an insider trading scheme, U.S. Attorney Philip R. Sellinger announced. Usama…